← Leaderboards
Brent Orvin Cezairliyan
Massachusetts General Hospital
$97,684
Attributed
$97,684
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $50.5K · FY2009–10$100K$75K$50K$25K$0
'09
'10
Funding mix
By agency
NIH$97,684 · 1
By mechanism
F32$97,684 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Gary B. Ruvkun$40,968,557
- Joshua M Kaplan$21,420,540
- Deborah T Hung$41,850,756
- Frederick M Ausubel$22,351,893
- Sanjay K Nigam$28,101,639
Others in their field
Top investigators on “Antimicrobial Drug”
- Vance G Fowler · Duke University$31,417,794
- Henry F Chambers · Duke University$30,735,128
- Kim Lewis · Northeastern University$24,610,510
- Mark S Smeltzer · University Of Arkansas Med Scis Ltl Rock$21,830,556
- David Heimbrook · Leidos Biomedical Research, Inc.$21,781,988
- Timothy Burgess · National Institute Of Allergy And Infectious Diseases$19,900,000
Research focus
Antimicrobial DrugBacterial Antibiotic ResistanceBiochemicalBiological ModelsCaenorhabditis ElegansDetectionGeneticImmuneKillingsLaboratoriesMeasurementMediatingMolecularMolecular WeightMutantNatural ImmunityNematodaOrganismPathogenPathogenesisPathogenic BacteriaPathway InteractionsPseudomonas AeruginosaPublic Health Relevance